Patent details
EP3102605 Title: COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER
Basic Information
- Publication number:
- EP3102605
- PCT Application Number:
- US2015014212
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP157034398
- PCT Publication Number:
- WO2015119930
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER
- French Title of Invention:
- ASSOCIATION D'UN ANTAGONISTE DU PD-1 ET D'UN INHIBITEUR DU VEGFR POUR TRAITER LE CANCER
- German Title of Invention:
- KOMBINATION AUS EINEM PD-1-ANTAGONISTEN UND EINEM VEGFR-INHIBITOR ZUR BEHANDLUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 03/02/2015
- Grant date:
- 14/11/2018
- EP Publication Date:
- 14/12/2016
- PCT Publication Date:
- 13/08/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/11/2018
- EP B1 Publication Date:
- 14/11/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/02/2035
- Renunciation date:
- Revocation date:
- 11/01/2024
- Annulment date:
Owner
- From:
- 26/05/2023
- Name:
- Merck Sharp & Dohme LLC
- Address:
- 126 East Lincoln Avenue P.O. Box 2000, Rahway, New Jersey 07065, United States (US)
- Name:
- Pfizer Inc.
- Address:
- 66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)
History of Owners
- From:
- 28/04/2023
- To:
- 26/05/2023
- Name:
- Merck Sharp & Dohme Corp.
- Address:
- 126 East Lincoln Avenue, Rahway, NJ 07065, United States (US)
- Name:
- Pfizer Inc.
- Address:
- 66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)
- From:
- 07/11/2018
- To:
- 28/04/2023
- Name:
- Merck Sharp & Dohme Corp.
- Address:
- 126 East Lincoln Avenue, Rahway, NJ 07065, United States (US)
- Name:
- Pfizer Inc.
- Address:
- 235 East 42nd Street, New York, NY 10017, United States (US)
Inventor
1
- Name:
- MARTINI, Jean-francois, Andre
- Address:
- United States (US)
2
- Name:
- MAURO, David, J.
- Address:
- United States (US)
3
- Name:
- TARAZI, Jamal, Christo
- Address:
- United States (US)
4
- Name:
- PERINI, Rodolfo, Fleury
- Address:
- United States (US)
Priority
- Priority Number:
- 201461935809 P
- Priority Date:
- 04/02/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/4439; A61K 39/395; A61P 35/00; C07K 16/28;
Publication
Bulletin
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2024/04
- Publication date:
- 11/03/2024
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates
European Patent Bulletin
1
- Issue number:
- 201846
- Publication date:
- 14/11/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201938
- Publication date:
- 18/09/2019
- Description:
- Opposition procedure started
3
- Issue number:
- 202409
- Publication date:
- 28/02/2024
- Description:
- Revocation of the European patent
4
- Issue number:
- 201851
- Publication date:
- 19/12/2018
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
5
- Issue number:
- 202326
- Publication date:
- 28/06/2023
- Description:
- Transfer of Rights
6
- Issue number:
- 202322
- Publication date:
- 31/05/2023
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 29/01/2024
- Last Annual Fee Paid Number:
- 10
- Last Annual Fee Paid Amount:
- 131 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|